The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells

Immunological Reviews

Volumn 165, Issue , 1998, Pages 231-247

  McAdam, Alexander J ^a   Schweitzer, A Nicola ^a   Sharpe, Arlene H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 2; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR;

B LYMPHOCYTE; CELLULAR IMMUNITY; CLONAL ANERGY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENETIC TRANSCRIPTION; GERMINAL CENTER; HELPER CELL; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSGENE;

EID: 0031727486     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065x.1998.tb01242.x     Document Type: Review

References (96)

1. Bretscher P, Cohn M. A theory of self-nonself discrimination. Science 1970;169:1042-1049.
2. Jenkins MK, Ashwell JD, Schwartz RH. Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells. J Immunol 1988;140:3324-3330.
3. Boussiotis VA, Freeman GJ, Gray G, Gribben J, Nadler LM. B7 but not intercellular adhesion molecule-1 co-stimulation prevents the induction of human alloantigen-specific tolerance. J Exp Med 1993;178:1753-1763.
4. Cross AH, et al. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 co-stimulation. J Clin Invest 1995;95:2783-2789.
5. Finck BK, Linsley PS, Wofsy D. Treatment of murine lupus with CTLA4Ig. Science 1994;265:1225-1227.
6. Perrin PJ, et al. Role of B7: CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J Immunol 1995;154:1481-1490.
7. Perez VL, Van Parijs L, Biuckians A, Zheng XX, Strom TB, Abbas AK. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 1997;6:411-417.
8. Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 1993;363:156-159.
9. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995;3:541-547.
10. Waterhouse P, et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995;270:985-988.
11. Freeman GJ, et al. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 1993;262:907-909.
12. Borriello F, et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997;6:303-313.
13. Gross JA, Callas E, Allison JP. Identification and distribution of the co-stimulatory receptor CD28 in the mouse. J Immunol 1992;149:380-388.
14. Harlan DM, Abe R, Lee KP, June CH. Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion. Clin Immunol Immunopathol 1995;75:99-111.
15. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
16. + T cells. Science 1997;276:273-276.
17. Hsueh YP, Liang HE, Ng SY, Lai MZ. CD28-co-stimulation activates cyclic AMP-responsive element-binding protein in T lymphocytes. J Immunol 1997;158:85-93.
18. De Boer M, Kasran A, Kwekkeboom J, Walter H, Vandenberghe P, Ceuppens JL. Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells. Eur J Immunol 1993;23:3120-3125.
19. Plet A, et al. Relief of cyclin A gene transcriptional inhibition during activation of human primary T lymphocytes via CD2 and CD28 adhesion molecules. Oncogene 1997;14:2575-2583.
20. Walunas TL, et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994;1:405-413.
21. Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 1995;182:459-465.
22. Tivol EA, et al. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J Immunol 1997;158:5091-5094.
23. Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Bluestone JA. CTLA-4: a negative regulator of autoimmune disease. J Exp Med 1996;184:783-788.
24. Perrin PJ, Maldonado JH, Davis TA, June CH, Racke MK. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J Immunol 1996;157:1333-1336.
25. Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997;7:445-450.
26. Linsley PS, Bradshaw J, Greene J, Peach R, Bennett KL, Mittler RS. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 1996;4:535-543.
27. Marengere LE, Waterhouse P, Duncan GS, Mittrucker HW, Feng GS, Mak TW. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 1996;272:1170-1173.
28. Wu Y, Guo Y, Huang A, Zheng P, Liu Y. CTLA-4-B7 interaction is sufficient to co-stimulate T cell clonal expansion. J Exp Med 1997;185:1327-1335.
29. Freeman GJ, et al. Murine B7-2, an alternative CTLA4 counter-receptor that co-stimulates T cell proliferation and interleukin 2 production. J Exp Med 1993;178:2185-2192.
30. Freeman GJ, Freedman AS, Segil JM, Lee G, Whitman JF, Nadler LM. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 1989;143:2714-2722.
31. Freeman GJ, et al. Cloning of B7-2: a CTLA-4 counter-receptor that co-stimulates human T cell proliferation. Science 1993;262:909-911.
32. Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, Peach R. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1994;1:793-801.
33. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell co-stimulation. Annu Rev Immunol 1996;14:233-258.
34. Lenschow DJ, et al. Differential up-regulation of the B7-1 and B7-2 co-stimulatory molecules after Ig receptor engagement by antigen. J Immunol 1994;153:1990-1997.
35. Azuma M, Ito D, Yagita H, et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993;366:76-79.
36. Freedman AS, Freeman GJ, Rhynhart K, Nadler LM. Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol 1991;137:429-437.
37. Larsen CP, et al. Regulation of immunostimulatory function and co-stimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 1994;152:5208-5219.
38. Inaba K, Steinman RM. Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release. J Exp Med 1984;160:1717-1735.
39. Hathcock KS, Laszlo G, Dickler HB, Bradshaw J, Linsley P, Hodes RJ. Identification of an alternative CTLA-4 ligand co-stimulatory for T cell activation. Science 1993;262:905-907.
40. Wetzler LM, Ho Y, Reiser H, Wetzler LW. Neisserial porins induce B lymphocytes to express co-stimulatory B7-2 molecules and to proliferate. J Exp Med 1996;183:1151-1159.
41. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM. IL-10 inhibits macrophage co-stimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993;151:1224-1234.
42. Barcy S, et al. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity. Int Immunol 1995;7:179-189.
43. Saha B, Das G, Vohra H, Ganguly NK, Mishra GC Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express co-stimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity. Eur J Immunol 1995;25:2492-2498.
44. + cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med 1993;177:1791-1796.
45. + T lymphocytes in the P815 tumor system in vitro. J Immunol 1996;156:465-472.
46. Yang G, Hellstrom KE, Hellstrom I, Chen L. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CILA-4 co-stimulatory molecules. J Immunol 1995;154:2794-2800.
47. Kuchroo VK, et al. B7-1 and B7-2 co-stimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80:707-718.
48. Schweitzer AN, Borriello F, Wong RC, Abbas AK, Sharpe AH. Role of co-stimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. J Immunol 1997;158:2713-2722.
49. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17:138-146.
50. Lenschow DJ, et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995;181:1145-1155.
51. Freeman GJ, et al. B7-1 and B7-2 do not deliver identical co-stimulatory signals, since B7-2 but not B7-1 preferentially co-stimulates the initial production of IL-4. Immunity 1995;2:523-532.
52. Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ. Comparative analysis of B7-1 and B7-2 co-stimulatory ligands: expression and function. J Exp Med 1994;180:631-640.
53. lo thymocytes in vivo. Science 1990;250:1720-1723.
54. Viola A, Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science 1996;273:104-106.
55. Lucas PJ, Negishi I, Nakayama K, Fields LE, Loh DY. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J Immunol 1995;154:5757-5768.
56. + T cells. J Exp Med 1997;186:757-766.
57. Boussiotis VA, Freeman GJ, Berezovskaya A, Barber DL, Nadler LM. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science 1997;278:124-128.
58. Jenkins MK. The role of cell division in the induction of clonal anergy. Immunol Today 1992;13:69-73.
59. Williams ME, Lichtman AH, Abbas AK. Anti-CD3 antibody induces unresponsiveness to IL-2 in Th1 clones but not in Th2 clones. J Immunol 1990;144:1208-1214.
60. Fitch FW, McKisic MD, Lancki DW, Gajewski TF. Differential regulation of murine T lymphocyte subsets. Annu Rev Immunol 1993;11:29-48.
61. + T lymphocytes from TCR transgenic mice. J Immunol 1994;152:5220-5225.
62. Schweitzer AN, Sharpe AH. Studies using APCs lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2, but not Th1, cytokine production. J Immunol 1998;161:2762-2771.
63. Rulifson IC, Sperling AI, Fields PE, Fitch FW, Bluestone JA. CD28 co-stimulation promotes the production of Th2 cytokines. J Immunol 1997;158:658-665.
64. Seder RA, Germain RN, Linsley PS, Paul WE. CD28-mediated co-stimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon γ production. J Exp Med 1994;179:299-304.
65. + T cells and defective antibody production in vivo. J Exp Med 1994;179:809-817.
66. Brown DR, Green JM, Moskowitz NH, Davis M, Thompson CB, Reiner SL. Limited role of CD28-mediated signals in T-helper subset differentiation. J Exp Med 1996;184:803-810.
67. Jenkins MK, Chen CA, Jung G, Mueller DL, Schwartz RH. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol 1990;144:16-22.
68. Perez VL, Lederer JA, Lichtman AH, Abbas AK. Stability of Th1 and Th2 populations. Int Immunol 1995;7:869-875.
69. Yi-qun Z, Joost van Neerven RJ, Kasran A, de Boer M, Ceuppens JL. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens. Int Immunol 1996;8:37-44.
70. Ronchese F, Hausmann B, Le Gros G. Interferon-γ- and interleukin-4-producing T cells can be primed on dendritic cells in vivo and do not require the presence of B cells. Eur J Immunol 1994;24:1148-1154.
71. Corry DB, Reiner SL, Linsley PS, Locksley RM. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J Immunol 1994;153:4142-4148.
72. Lin H, et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993;178:1801-1806.
73. Sayegh MH, Turka LA. T cell co-stimulatory pathways: promising novel targets for immunosuppression and tolerance induction. J Am Soc Nephrol 1995;6:1143-1450.
74. Pearson TC, et al. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism. Transplantation 1996;61:997-1004.
75. Ferguson SE, Han S, Kelsoe G, Thompson CB. CD28 is required for germinal center formation. J Immunol 1996;156:4576-4581.
76. Han S, Hathcock K, Zheng B, Kepler TB, Hodes R, Kelsoe G. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J Immunol 1995;155:556-567.
77. Zheng B, Han S, Takahashi Y, Kelsoe G. Immunosenescence and germinal center reaction. Immunol Rev 1997;160:63-77.
78. Khoruts A, Mondino A, Pape KA, Reiner SL, Jenkins MK. A natural immunological adjuvant enhances T cell donal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J Exp Med 1998;187:225-236.
79. Kawabe T, et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994;1:167-178.
80. Xu J, et al. Mice deficient for the CD40 ligand. Immunity 1994;1:423-431.
81. Ranheim EA, Kipps TJ. Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L. Cell Immunol 1995;161:226-235.
82. Roy M, Aruffo A, Ledbetter J, Linsley P, Kehry M, Noelle R. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur J Immunol 1995;25:596-603.
83. Gause WC, et al. CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. J Immunol 1997;158:4082-4087.
84. Wu Y, Zhou Q, Zheng P, Liu Y. CD28-independent induction of T-helper cells and immunoglobulin class switches requires co-stimulation by the heat-stable antigen. J Exp Med 1998;187:1151-1156.
85. + T-cell responses. Curr Biol 1994;4:499-505.
86. Shahinian A, et al. Differential T cell co-stimulatory requirements in CD28-deficient mice. Science 1993;261:609-612.
87. Kundig TM, et al. Duration of TCR stimulation determines co-stimulatory requirement of T cells. Immunity 1996;5:41-52.
88. Guerder S, Carding SR, Flavell RA. B7 co-stimulation is necessary for the activation of the lytic function in cytotoxic T lymphocyte precursors. J Immunol 1995;155:5167-5174.
89. Nathenson N, et al. Viral pathogenesis. 1st ed. Philadelphia: Lippencott-Raven; 1997.
90. + T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. Science 1991;251:1228-1231.
91. De Simone R, et al. The co-stimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol 1995;54:175-187.
92. Gribben JG, et al. Complete blockade of B7 family-mediated co-stimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool. Blood 1996;87:4887-4893.
93. Durie FH, et al. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J Clin Invest 1994;94:1333-1338.
94. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998;393:480-3.
95. + T-helper and a T-killer cell. Nature 1998;393:474-478.
96. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998;393:478-480.